Collaboration will support Sanofi’s use of CytoReason’s computational disease models to develop new targets for inflammatory bowel disease (IBD). Read...
Read MoreIn this episode of FINTECH.TV, we are joined by Jon Medved, CEO of OurCrowd, to discuss the upcoming OurCrowd Global Investor Summit in Jerusalem. Jon shares the exciting lineup of entrepreneurs, fund managers, corporations, and individual investors who will be attending the summit, as well as the diverse range of startups that will be showcasing their cutting-edge technologies in areas such as energy, AgTech, food tech, cybersecurity, and healthcare. The summit will also feature thought leaders in the tech and investment industry and experts in tackling greenhouse gas emissions and saving the planet. Watch the video...
Read More
Top investment opportunitiesStartup of the Week: CropX, the future of farming Quantum Machines raises $20M as adoption growsOurCrowd Summit: Enter a world of angels and unicornsMicrosoft Sentinel taps Cyfirma for cybersecurity boostOurCrowd hosts Spanish innovation officialsGeneral Mills launches cream cheese with RemilkTetra Pak signs deal with Fresh Start incubatorFreightos: Record transactions and bookings in 2022CNN: Insightec’s ultrasound surgery safely targets faulty brain circuitsMore than 3,900 high-tech jobs Startup of the WeekCropX: The future of farming One of the world’s most pressing problems is figuring out how to feed a rapidly growing global population in a changing climate, while minimizing environmental damage. AgTech pioneer CropX’s SaaS platform uses artificial intelligence to analyze data from proprietary in-ground sensors, combined with precise weather, satellite imaging, topography, and other data sources. The information provided by CropX allows farmers to improve yields, reduce energy costs and cut greenhouse emissions, while saving up to 50% in water consumption and up to 20% in fertilizer usage. Since 2019, CropX has deployed over 15,000 systems with over 2,500 paying customers in more than 60 countries. The company’s growing...
Read MoreNEW YORK, Jan. 20, 2023 /PRNewswire/ — Ro, the leading direct-to-patient healthcare company, announced today the launch of the Ro Body Program, a comprehensive weight loss program that provides access to GLP-1 medications, the most effective prescription obesity treatments available. Ro aims to help millions of Americans living with obesity achieve their weight loss goals through access to prescription treatment supported by personalized provider care, diagnostic testing with at-home sample collection, and 1:1 coaching from nurses. Read more...
Read MoreOmer Keilaf is not bothered by Tesla abandoning LiDAR technology, nor worried when investors ask what’s going on with Innoviz’s stock. The prodigy of Israeli auto-tech is in a confident mood: “At the current price of LiDARs, I can sell 30 pieces to Tesla at the same cost it demands from its customers to make a vehicle autonomous” Read more...
Read More
